SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950138-16-000789
Filing Date
2016-02-02
Accepted
2016-02-02 16:10:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 intracelllular13ga_01212016.htm SC 13G/A 89132
  Complete submission text file 0000950138-16-000789.txt   90466
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87380 | Film No.: 161380998
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4800 MAIN STREET SUITE 100 KANSAS CITY MO 64112
Business Address
Sosland Morton I. (Filed by) CIK: 0001585668 (see all company filings)

Type: SC 13G/A